Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

Muscle pathology in neuromuscular disorders

  • Park, Young-Eun (Department of Neurology, Pusan National University School of Medicine) ;
  • Shin, Jin-Hong (Department of Neurology, Pusan National University School of Medicine) ;
  • Kim, Dae-Seong (Department of Neurology, Pusan National University School of Medicine)
  • Received : 2020.07.17
  • Accepted : 2020.08.11
  • Published : 2020.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Muscle pathology findings may guide the diagnosis of neuromuscular disorders since they are helpful for understanding the pathological processes causing muscle weakness and also provide significant clues for the diagnosis of muscle diseases. Recent advances in molecular genetics mean that a muscle biopsy can be omitted when diagnosing inherited muscle diseases. However, the muscle pathology can still play a role in those cases and its findings are also required when diagnosing inflammatory myopathies.

Keywords

References

  1. Suzuki S, Uruha A, Suzuki N, Nishino I. Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology. Autoimmun Rev 2017;16:693-700. https://doi.org/10.1016/j.autrev.2017.05.003
  2. Dubowitz V, Sewry CA, Oldfors A. Normal muscle. In: Dubowitz V, Sewry CA, Oldfors A, Lane R, eds. Muscle biopsy: a practical approach. 4th ed. London: Elsevier, 2013;28-54.
  3. Sewry CA, Goebel HH. General pathology of muscle disease. In: Goebel HH, Sewry CA, Weller RO, eds. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell, 2013;19-38.
  4. Dubowitz V, Sewry CA, Oldfors A. Muscular dystrophies and allied disorders I: Duchenne and Becker muscular dystrophy. In: Dubowitz V, Sewry CA, Oldfors A, Lane R, eds. Muscle biopsy: a practical approach. 4th ed. London: Elsevier, 2013;250-275.
  5. Barresi R, Brown SC. Dystrophin and its associated glycoprotein complex. In: Goebel HH, Sewry CA, Weller RO, eds. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell, 2013;95-101.
  6. Dubowitz V, Sewry CA. Muscular dystrophies and allied disorders IV: Emery-Dreifuss muscular dystrophy and similar syndromes. In: Dubowitz V, Sewry CA, Oldfors A, Lane R, eds. Muscle biopsy: a practical approach. 4th ed. London: Elsevier, 2013;331-344.
  7. Kim DS. Diagnostic significance of immunohistochemical staining in muscular dystrophy. J Korean Neurol Assoc 2006;24:1-13.
  8. Park YE, Shin JH, Kim HS, Lee CH, Kim DS. Characterization of congenital myopathies at a Korean neuromuscular center. Muscle Nerve 2018;58:235-244. https://doi.org/10.1002/mus.26147
  9. Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 2001;50:312-320. https://doi.org/10.1002/ana.1080
  10. Lee JM, Lim JG, Shin JH, Park YE, Kim DS. Clinical and genetic diversity of nemaline myopathy from a single neuromuscular center in Korea. J Neurol Sci 2017;383:61-68. https://doi.org/10.1016/j.jns.2017.10.020
  11. Wattanasirichaigoon D, Swoboda KJ, Takada F, Tong HQ, Lip V, Iannaccone ST, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002;59:613-617. https://doi.org/10.1212/WNL.59.4.613
  12. Park YE, Shin JH, Kang B, Lee CH, Kim DS. NEB-related core-rod myopathy with distinct clinical and pathological features. Muscle Nerve 2016;53:479-484. https://doi.org/10.1002/mus.24966
  13. Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology 2019;93:e298-e305. https://doi.org/10.1212/WNL.0000000000007777
  14. Park YE, Choi YC, Bae JS, Lee CH, Kim HS, Shin JH, et al. Clinical and pathological features of Korean patients with DNM2-related centronuclear myopathy. J Clin Neurol 2014;10:24-31. https://doi.org/10.3988/jcn.2014.10.1.24
  15. Romero NB, Laforte J. Centronuclear myopathies. In: Goebel HH, Sewry CA, Weller RO, eds. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell, 2013;134-144.
  16. Dubowitz V, Sewry CA. Myopathies with vacuoles. In: Dubowitz V, Sewry CA, Oldfors A, Lane R, eds. Muscle biopsy: a practical approach. 4th ed. London: Elsevier, 2013;406-422.
  17. Mair D, Biskup S, Kress W, Abicht A, Bruck W, Zechel S, et al. Differential diagnosis of vacuolar myopathies in the NGS era. Brain Pathol 2020;30:877-896.
  18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347. https://doi.org/10.1056/NEJM197502132920706
  19. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713. https://doi.org/10.1002/ana.410380504
  20. Tanboon J, Nishino I. Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr Opin Neurol 2019;32:704-714. https://doi.org/10.1097/WCO.0000000000000740
  21. Uruha A, Suzuki S, Suzuki N, Nishino I. Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1. Brain 2016;139(Pt 9):e50. https://doi.org/10.1093/brain/aww125